Sign in
  Edit search
Augmenting drug-carrier compatibility improves tumour nanoth…
Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.
Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.
Article, Chapter
Authors: Yiming Y Zhao
Publication: Nature Communications, Volume:7, Page(s):11221
Published: Nature Publishing Group UK, 2016-4-13
ISSN: 2041-1723
DOI: 10.1038/ncomms11221
  Full text availability for this item
View Full Text Source:Nature Communications,Nature Communications,Nature Open Access Content Opens in new Window
Journal:  Nature Communications Source:Nature Open Access Content Opens in new Window
Collection:  Nature Open Access Content Opens in new Window
Coverage:
  • 2010-12~present; volume:1~present;issue:1~present
Report a broken link
View Full Text Source:Nature Communications,Nature Communications,Nature All Titles Opens in new Window
Journal:  Nature Communications Source:Nature All Titles Opens in new Window
Collection:  Nature All Titles Opens in new Window
Coverage:
  • 2010-12~present; volume:1~present;issue:1~present
Report a broken link
View Full Text Source:Nature Communications,Nature Communications,Directory of Open Access Journals (All titles) Opens in new Window
Journal:  Nature Communications Source:Directory of Open Access Journals (All titles) Opens in new Window
Collection:  Directory of Open Access Journals (All titles) Opens in new Window
Coverage:
  • 2013-12~2024-04
Report a broken link
View Full Text Source:Nature Communications,Nature Communications,PubMed Central Opens in new Window
Journal:  Nature Communications Source:PubMed Central Opens in new Window
Collection:  PubMed Central Opens in new Window
Coverage:
  • 2012~2024; volume:3~volume:15
Report a broken link
  Print copies at your library
Check Holdings in Worldcat
  Request a copy of this item
Cite this item